Satoshi Nishida

Dr. Satoshi Nishida

Department of Microbiology and Immunology, Teikyo University School of Medicine, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
SNSatoshi Nishida
Satoshi Nishida
YOYasuo Ono
Yasuo Ono

18 November 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
SNSatoshi Nishida
Satoshi Nishida
NMNaohisa Matsunaga
Naohisa Matsunaga
YKYuta Kamimura
Yuta Kamimura
SIShinobu Ishigaki
Shinobu Ishigaki
TFTaiji Furukawa
Taiji Furukawa
YOYasuo Ono
Yasuo Ono
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.

1 October 2018 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
SNSatoshi Nishida
Satoshi Nishida
YOYasuo Ono
Yasuo Ono
Introduction: The pathogenicity of fatal-outbreak Acinetobacter baumannii isolates has not been fully investigated. This study aimed to compare the pathogenicity between A. baumannii clinical isolates, including multidrug-resistant A. baumannii (MDRA). Materials and methods: Antibiotic susceptibility was determined by the broth microdilution method, and drug-resistant genes were characterized by PCR and sequencing. The pathogenicity of A. baumannii and antibiotic responses were evaluated using the Galleria mellonella infection model. Clinical isolates from an A. baumannii outbreak at our hospital were categorized using the pulse-field gel electrophoresis. Of the 16 isolated A. baumannii clones, 12 clones were resistant to carbapenems (meropenem and imipenem), of which 10 clones were also resistant to amikacin and ciprofloxacin (MDRAs). MDRAs had OXA-51-like β-lactamase gene harboring an insertion sequence in the promoter region and armA gene encoding 16S rRNA methyltransferase. Results: Carbapenem- and/or amikacin-resistant A. baumannii were more pathogenic than carbapenem- and/or amikacin-sensitive A. baumannii in G. mellonella. MDRA isolate TK1033 was more virulent than other A. baumannii isolates. However, TK1033 was sensitive to the fourth-generation cephalosporin cefozopran in addition to minocycline, tigecycline, and polymyxins (colistin and polymyxins B) in vitro and in vivo in the MDRA-G. mellonella infection model. Conclusion: Differences in pathogenicity among carbapenem-resistant A. baumannii clones are consistent with heterogeneous clinical outcomes. Strain TK1033, isolated frequently during the outbreak, was the most virulent, whereas preoutbreak isolate TK1032 was less virulent than other A. baumannii isolates. Infection by high-virulence isolates may be more prevalent during outbreaks. These strains may prove valuable for investigating MDRA virulence and novel therapeutics.

1 January 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YUYuka Unno
Yuka Unno
YSYoshinori Sato
Yoshinori Sato
SNSatoshi Nishida
Satoshi Nishida
ANAkiyo Nakano
Akiyo Nakano
RNRyuichi Nakano
Ryuichi Nakano
YOYasuo Ono
Yasuo Ono
Acinetobacter baumanniiis one of the most important nosocomial opportunistic pathogen worldwide. In addition, obesity has been associated with an increased risk of nosocomial infection, suggesting that there may be an association betweenA. baumanniiand white adipose tissue. However, the effects ofA. baumanniion adipocytes have not been well studied at the molecular level. Here, we investigated the potential role ofA. baumannii-derived lipopolysaccharides (LPS) as signaling molecules that affect adipocyte functionality. We tested the effect of increasing concentrations ofA. baumannii-derived LPS (10, 100, or 1000 ng/mL) on the 3T3-L1 adipocyte cell line. Exposure to LPS was found to increase the expression of several adipokines (e.g., MIP-2, MCP-1, TNF-α, IL-6, lipocalin-2, and FABP4) in 3T3-L1 adipocytes and significantly reduced the expression of leptin and adiponectin. The effects ofA. baumannii-derived LPS on MIP-2 expression were similar in comparison with that of LPS prepared fromPseudomonas aeruginosaandEscherichia coliin our cell culture-based system. This study suggests thatA. baumannii-derived LPS functions as a signaling molecule that impacts the inflammatory function of white adipose tissue on the level of gene expression.

1 August 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SNSatoshi Nishida
Satoshi Nishida
MNMasataka Nakagawa
Masataka Nakagawa
YOYuki Ouchi
Yuki Ouchi
CSChiaki Sakuma
Chiaki Sakuma
YNYu Nakajima
Yu Nakajima
YOYasuo Ono
Yasuo Ono

1 October 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
SNSatoshi Nishida
Satoshi Nishida
SIShinobu Ishigaki
Shinobu Ishigaki
MAMiwa Asahara
Miwa Asahara
TFTaiji Furukawa
Taiji Furukawa
YOYasuo Ono
Yasuo Ono